Today: 9 June 2026
Rocket Lab stock slides again as RKLB pulls back from January highs
2 February 2026
1 min read

Rocket Lab stock slides again as RKLB pulls back from January highs

New York, Feb 2, 2026, 14:48 EST — Regular session

Rocket Lab shares dropped over 5% Monday afternoon, deepening a steep retreat from their January peak as investors reconsidered the company’s growth prospects. By 2:28 p.m. ET, the stock slid 5.35% to $75.79, after dipping to $75.17—roughly 24% shy of its Jan. 16 high of $99.58.

This move is significant as Rocket Lab has become a high-expectation stock, prone to sharp swings on policy news and timing delays. Its recent volatility has drawn heavy interest from both bulls and bears.

Investors are weighing how much of Rocket Lab’s backlog depends on government contracts and how fast it can expand beyond its Electron rocket into more lucrative areas. That discussion is growing louder as the stock loses steam.

Talk around NASA’s Mars Sample Return mission is causing fresh uncertainty. The plan aims to retrieve Martian samples gathered by the Perseverance rover and bring them back to Earth. But a Nasdaq.com article published late Saturday reported that U.S. Congress has pulled funding for the current program, despite Rocket Lab’s $4 billion proposal.

The valuation has intensified the response. Barron’s noted Rocket Lab is currently trading at roughly 45 times its projected sales over the next 12 months, with analysts not expecting a full-year profit until 2027. That leaves scant margin for error.

Rocket Lab has maintained its launch rhythm with Electron. Last week, it completed its 81st Electron mission from New Zealand, putting a satellite into orbit for the Korea Advanced Institute of Science and Technology. CEO Sir Peter Beck described the two launches within eight days as “a strong start to the year.” GlobeNewswire

Investors are zeroed in on Neutron, Rocket Lab’s bigger rocket aimed at taking on SpaceX’s Falcon 9. Space.com reports the “Hungry Hippo” payload fairing—Neutron’s satellite-protecting shell—has touched down at Virginia’s Mid-Atlantic Regional Spaceport. But a failed pressure test on the main stage has thrown the first-flight schedule into doubt.

But when a stock is priced for speed, even minor setbacks can sting. Any hiccup in Neutron’s development, a slowdown in launches, or conservative forecasts on space systems demand could weigh on the shares.

Rocket Lab is set to release its Q4 and full-year 2025 results after the U.S. market closes on Feb. 26, with a conference call scheduled for 5 p.m. ET.

Stock Market Today

  • NYSE Update: HUD Sec. Turner Highlights National Homeownership Month Amid Market Moves
    June 9, 2026, 10:01 AM EDT. The New York Stock Exchange (NYSE) highlighted key market developments on June 9, 2026, including chip stocks boosting the S&P 500 early in the week. Fintech firm Thunes opened a new office in New York City to enhance global money movement solutions for U.S. businesses. Philips released its 2026 Future Health Index U.S. report. U.S. Secretary of Housing and Urban Development Scott Turner will appear on NYSE Live to discuss efforts to empower homebuilders and ease regulations, spotlighting National Homeownership Month. Cloudflare held its 2026 Investor Day, while Man Group rang the NYSE Closing Bell the previous day. The NYSE encourages investors to access the TV App for detailed market insights and IPO activity.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Why Coherent stock is jumping today as a unit sale closes and earnings loom
Previous Story

Why Coherent stock is jumping today as a unit sale closes and earnings loom

XPeng stock sinks on January delivery update as China EV demand jitters hit sector
Next Story

XPeng stock sinks on January delivery update as China EV demand jitters hit sector

Go toTop